Table 1 Baseline demographic features and laboratory measurements by treatment allocation

Number randomised (N)

51

53

Age (years) (Median, IQR)

60 (48,70)

65 (54,71)

 Male: Female

35:16

33:20

 % of females:

31.4%

37.8%

Diabetes: No Diabetes:

15:36

11:42

Percentage with Diabetes:

29.4%

20.8%

Previous CAD:

15

10

No previous CAD:

36

43

Percentage with CAD:

29.4%

18.9%

Previous Vascular disease (including CAD):

16

12

No Previous vascular disease:

35

41

Percentage with previous vascular disease:

31.4%

22.6%

Duration on RRT:

(Median, IQR)

2.5 years

(1.5,5.0)

2.0 years

(1.0,5.7)

Serum Phosphate (Mean, SD)

(P = 0.1)

2.09 +/− 0.4 mmol/L

(6.5 +/− 1.2 mg/dL)

2.2 +/−  0.4 mmol/L

(6.8 +/−  1.2 mg/dL)

Corrected calcium (Mean, SD)

(P = 0.4)

2.37 +/−  0.4 mmol/L

9.5 +/−  1.2 mg/dL

2.32 +/−  0.2 mmol/L

9.3 +/− 0.8 mg/dL

Serum PTH (pg/ml)

(Mean, SD) (P = 0.8)

418 (273, 571)

392 (174, 675)

Serum Albumin (g/L)

(Mean, SD) (P = 0.2)

32.7 +/−  7.7

34.6 +/−  6.9

Serum Cholesterol (mmol/L) (Mean, SD) (P = 0.9)

4.03 +/− 1.2

4.08 +/−  1.6